The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial

David Sinclair @DavidSinclair · Dec 15, 2022

A recent paper on the safety and efficacy of NMN worth a read. Will summarize later

Paper Dec 8, 2022

Recommended by 1 person

1 mention